Altria - sells a simple product with a government-enforced monopoly, low/no R&D costs, extremely reliable cash-flows. Company can pay out approx 80% of FCF per year as cash dividends and use the rest to buy back and cancel outstanding stock to continuously increase EPS. Additionally, the current 27% stake in SAB Miller looks increasingly likely to convert to an equity stake in ABI/Miller (if the acquisition clears), and Altria was already getting about $1 billion/year in dividends from SAB Miller (that had grown about 10% per year for the past 5 years), so going forward non-tobacco income is likely to continue to increase.
From personal experience: I regularly purchase shares of Altria (weekly, monthly) and have since mid-2009. I don't pay transaction costs due to my brokerage account balance with Wells Fargo; my yield on cost for some of my earliest purchases in 2009 is now 15%.